- DawaDose Closes Pre-Seed Round Backed by Angel Investors
-
The funding round aims to expand operations in the digital pharmacy sector.
DawaDose, a healthtech startup specializing in digital solutions for the pharmaceutical sector, has successfully closed its Pre-Seed funding round with the participation of a group of angel investors.
The investment aims to accelerate the company’s efforts in advancing digital pharmacy services across the region.
Funding Details
The round marks a pivotal step in DawaDose’s journey to build a fully integrated digital ecosystem that seamlessly connects consumers with pharmacies and drug distributors in a secure and efficient manner.
The company has also announced the official establishment of its headquarters in Saudi Arabia, positioning the Kingdom as its hub for development and operations, as well as a launchpad for expansion into the Saudi and wider Gulf markets.
Founders’ Statements
Roshdy Abdelghany, Co-Founder and CEO of DawaDose, commented:
“This funding supports our vision to accelerate access to digital healthcare across the Middle East, starting from Saudi Arabia.”
Meanwhile, Osama Al-Mabroum, Co-Founder and Business Development Director, added:
“We are building DawaDose as a Saudi company with a global vision. This is just the beginning of reshaping e-pharmacy and digital pharmaceutical commerce in the region.”
Expansion Plans
Looking ahead, DawaDose plans to expand further within Saudi Arabia and beyond, aligning with the Kingdom’s ongoing digital transformation in healthcare and supporting the goals of Saudi Vision 2030 to foster innovation and smart health services.
العربية (Arabic) To read the article in Arabic, click here
